FindTrial
Sign In

A Clinical Trial to study the incidence of hemoglobinopathies in antenatal women lessthan 20 weeks attending tertiary care centre

Antenatal Screening for Hemoglobinopathies in a Tertiary Care Centre - One Year Descriptive Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/01/048851
Enrollment
196
Registered
2023-01-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Jawaharlal Nehru Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Antenatal women with period of gestation less than 20 weeks(calculated by reliable LMP/scan) attending OBGYN OPD

Exclusion criteria

Exclusion criteria: women who are already known cases of hemoglobinopathies and who are not willing to participate in this study

Design outcomes

Primary

MeasureTime frame
Screening of antenatal women lessthan 20 weeks POG for hemoglobinopathies for the prevalence of hemoglobinopathies in antenatal women attending tertiary care centreTimepoint: 1 year—

Secondary

MeasureTime frame
To screen Preganant women for hemoglobinopathies and increase awareness among general population and offering prenatal diagnosis to couples at risk of having abnormal childTimepoint: 1 year—

Countries

India

Contacts

Public ContactGURRALA SNEHA

Jawaharlal Nehru Medical College

mbbellad@hotmail.com9448124893

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026